Jackson News Reporter

Active Pharmaceutical Ingredient (API) Market Registering A CAGR Of 6.8% For The Projected Period From 2019 To 2026 : Grand View Research Inc.

 Breaking News
  • No posts were found

Active Pharmaceutical Ingredient (API) Market Registering A CAGR Of 6.8% For The Projected Period From 2019 To 2026 : Grand View Research Inc.

July 02
21:48 2019
Active Pharmaceutical Ingredient (API) Market Registering A CAGR Of 6.8% For The Projected Period From 2019 To 2026 : Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global Active Pharmaceutical Ingredient (API) market size was valued at USD 158.15 billion in 2018 and is estimated to expand at a CAGR of 6.8% over the forecast years.

The global active pharmaceutical ingredient (API) market size is expected to reach at USD 268.12 billion by 2026 registering a CAGR of 6.8%, according to a new report by Grand View Research, Inc. Rising trend of outsourcing APIs and growing prevalence of various target diseases, such as cancer, Cardiovascular Disease (CVDs) are anticipated to boost the market. Huge capital is required in API production as the process needs extremely systematic protocols. Pharmaceutical companies can actually benefit from outsourcing API production, as it eliminates the need for installing expensive manufacturing units. Moreover, strategic outsourcing enables companies to focus on their core competencies, ultimately resulting in increased productivity. These factors are also estimated to drive the demand in future.

Growing geriatric population across the globe is also likely to contribute to the market expansion. Estimates published by the WHO suggest that the global base of population pertaining to the age group of 65 years and above is expected to rise from 7% in 2000 to 16% in 2050. Latin America, in particular, is projected to witness fastest growth, in terms of geriatric population, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%). Patent expiration of blockbuster drugs, growing outsourcing activities due to high manufacturing costs, and stringent regulations for API production are expected to intensify the market competition. As part of strategic geographic expansion, many companies are setting up manufacturing plants in the developing regions like Asia Pacific.

U.S. Active Pharmaceutical Ingredient (API) market size, by type of synthesis, 2014 - 2026 (USD Billion)

Request a sample Copy of the Active Pharmaceutical Ingredient (API) Market Research Report @  https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market/request/rs1

Key Takeways Of The Report :

  • Synthetic APIs held the largest share of the API market in 2018 owing to easy availability of raw materials and easier protocols for synthesis of these molecules
  • Biotech APIs are estimated to register the highest CAGR over the forecast years due to rising demand for biopharmaceuticals and higher efficiency of these molecules
  • Captive manufacturers led the market owing to intensive capitalization of major key players in development of high-end manufacturing facilities
  • Merchant manufacturers segment is expected to be the fastest-growing segment over the forecast period
  • Generic APIs are expected to register a lucrative CAGR over the forecast period on account of factors, such as expiration of patents of branded drugs and lower cost
  • Cardiology segment led the overall market in 2018. Increasing prevalence of target diseases worldwide and high demand for fast-acting drugs are some of the key factors responsible for the segment growth
  • North America held the largest market share in 2018. Asia Pacific is estimated to be the fastest-growing region expanding at a CAGR of 8.2% over the estimated period
  • Some of the major companies in the market are Teva Pharmaceutical Industries Ltd.; AbbVie Inc.; Boehringer Ingelheim International GmbH; Cipla Inc.; Merck & Co., Inc.; Bristol-Myers Squibb Company; Albemarle Corporation; Mylan N.V.; Aurobindo Pharma; Sun Pharmaceutical Industries Ltd.; and Dr. Reddy’s Laboratories Ltd.

Global Active Pharmaceutical Ingredient (API) market share, by application, 2018 (%)

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/658/ibb

Grand View Research has segmented the global Active Pharmaceutical Ingredient (API) market on the basis of type of synthesis, type of manufacturer, type, application, and region:

API Type of Synthesis Outlook (Revenue, USD Billion, 2014 – 2026)

  • Biotech
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • Synthetic

API Type of Manufacturer Outlook (Revenue, USD Billion, 2014 – 2026)

  • Captive
  • Merchant

API Type Outlook (Revenue, USD Billion, 2014 – 2026)

  • Generic
  • Innovative

API Application Outlook (Revenue, USD Billion, 2014 – 2026)

  • Cardiology
    • Generic
    • Innovative
  • Oncology
    • Generic
    • Innovative
  • CNS & Neurology
    • Generic
    • Innovative
  • Orthopedic
    • Generic
    • Innovative
  • Endocrinology
    • Generic
    • Innovative
  • Pulmonology
    • Generic
    • Innovative
  • Gastroenterology
    • Generic
    • Innovative
  • Nephrology
    • Generic
    • Innovative
  • Ophthalmology
    • Generic
    • Innovative
  • Others

API Regional Outlook (Revenue, USD Billion, 2014 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa

Browse Related Report:

CIS Insulin Market : https://www.grandviewresearch.com/industry-analysis/cis-insulin-market

Antidiabetics Market :  https://www.grandviewresearch.com/industry-analysis/antidiabetics-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

 

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Categories